SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour

Olli-Pekka Pulkka, Bengt Nilsson, Maarit Sarlomo-Rikala, Peter Reichardt, Mikael Eriksson, Kirsten Sundby Hall, Eva Wardelmann, Aki Vehtari, Heikki Joensuu, Harri Sihto

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalBritish Journal of Cancer
Volume116
Issue number9
Pages (from-to)1195-1202
Number of pages8
ISSN0007-0920
DOIs
Publication statusPublished - Apr 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • gastrointestinal stromal tumour
  • SLUG
  • SNAI2
  • survival
  • proliferation
  • apoptosis
  • C-KIT
  • ADJUVANT IMATINIB
  • P53-MEDIATED APOPTOSIS
  • CISPLATIN RESISTANCE
  • SIGNALING PATHWAY
  • RANDOMIZED-TRIAL
  • OVARIAN-CANCER
  • MUTATIONS
  • MESYLATE
  • SNAIL
  • 3122 Cancers

Cite this

Pulkka, O-P., Nilsson, B., Sarlomo-Rikala, M., Reichardt, P., Eriksson, M., Hall, K. S., Wardelmann, E., Vehtari, A., Joensuu, H., & Sihto, H. (2017). SLUG transcription factor: a pro-survival and prognostic factor in gastrointestinal stromal tumour. British Journal of Cancer, 116(9), 1195-1202. https://doi.org/10.1038/bjc.2017.82